PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,259 | -33.8% | 14,522 | +5.5% | 0.01% | -33.3% |
| Q2 2023 | $183,114 | +18.2% | 13,768 | +2.9% | 0.01% | +12.5% |
| Q1 2023 | $154,929 | +36.1% | 13,379 | -3.8% | 0.01% | +60.0% |
| Q4 2022 | $113,808 | +64.2% | 13,913 | +16.5% | 0.01% | +66.7% |
| Q3 2022 | $69,312 | +14.6% | 11,940 | -12.7% | 0.00% | 0.0% |
| Q2 2022 | $60,461 | -44.4% | 13,679 | +14.5% | 0.00% | -25.0% |
| Q1 2022 | $108,690 | -89.7% | 11,944 | -76.8% | 0.00% | -71.4% |
| Q4 2021 | $1,052,258 | -19.9% | 51,430 | 0.0% | 0.01% | -26.3% |
| Q3 2021 | $1,314,037 | -28.8% | 51,430 | -2.6% | 0.02% | -26.9% |
| Q2 2021 | $1,845,682 | +15.3% | 52,779 | +9.8% | 0.03% | +8.3% |
| Q1 2021 | $1,601,112 | +24.5% | 48,067 | -3.0% | 0.02% | +26.3% |
| Q4 2020 | $1,285,664 | +179.3% | 49,563 | +6.3% | 0.02% | +137.5% |
| Q3 2020 | $460,317 | +187.8% | 46,638 | +0.6% | 0.01% | +166.7% |
| Q2 2020 | $159,970 | +13.8% | 46,368 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $140,567 | -40.9% | 45,937 | -0.7% | 0.00% | -25.0% |
| Q4 2019 | $237,797 | +18.3% | 46,264 | +18.8% | 0.00% | +33.3% |
| Q3 2019 | $201,003 | -22.7% | 38,954 | -9.3% | 0.00% | -25.0% |
| Q2 2019 | $259,962 | -11.6% | 42,969 | +5.7% | 0.00% | -20.0% |
| Q1 2019 | $294,037 | -7.1% | 40,669 | -4.9% | 0.01% | -16.7% |
| Q4 2018 | $316,402 | +40.3% | 42,757 | +2.6% | 0.01% | +50.0% |
| Q3 2018 | $225,478 | -99.8% | 41,678 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $147,957,000 | +108.4% | 41,678 | +20.4% | 0.00% | +100.0% |
| Q1 2018 | $70,984,000 | +147783.3% | 34,626 | +89.1% | 0.00% | 0.0% |
| Q4 2017 | $48,000 | -77.1% | 18,307 | -69.0% | 0.00% | 0.0% |
| Q2 2017 | $210,000 | -31.1% | 59,018 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $305,000 | +35.6% | 59,018 | -0.5% | 0.00% | 0.0% |
| Q4 2016 | $225,000 | -57.6% | 59,287 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $531,000 | +40.5% | 59,287 | +10.5% | 0.00% | +33.3% |
| Q2 2016 | $378,000 | -12.1% | 53,674 | +6.1% | 0.00% | 0.0% |
| Q1 2016 | $430,000 | -21.5% | 50,590 | +21.1% | 0.00% | -25.0% |
| Q4 2015 | $548,000 | +258.2% | 41,762 | 0.0% | 0.00% | +300.0% |
| Q3 2015 | $153,000 | -29.8% | 41,762 | +10.3% | 0.00% | -50.0% |
| Q2 2015 | $218,000 | -12.4% | 37,859 | -11.0% | 0.00% | 0.0% |
| Q1 2015 | $249,000 | -25.4% | 42,556 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $334,000 | +59.8% | 42,556 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $209,000 | -20.5% | 42,556 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $263,000 | +15.4% | 42,556 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $228,000 | +2.2% | 42,556 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $223,000 | -5.1% | 42,556 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $235,000 | – | 42,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |